Publications found:
36,694
Sort by:
Mavyret- Drug Insight, 2019
US$ 1,000.00
... the Mavyret SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Mavyret Access to Mavyret API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Mavyret patents ...
July 2019
35 pages
Mayzent- Drug Insight, 2019
US$ 1,000.00
... the Mayzent SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Mayzent Access to Mayzent API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Mayzent patents ...
July 2019
35 pages
Nerlynx- Drug Insight, 2019
US$ 1,000.00
... the Nerlynx SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Nerlynx Access to Nerlynx API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Nerlynx patents ...
July 2019
35 pages
Symdeko- Drug Insight, 2019
US$ 1,000.00
... the Symdeko SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Symdeko Access to Symdeko API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Symdeko patents ...
July 2019
35 pages
Tremfya- Drug Insight, 2019
US$ 1,000.00
... the Tremfya SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Tremfya Access to Tremfya API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Tremfya patents ...
July 2019
35 pages
Verzenio- Drug Insight, 2019
US$ 1,000.00
... the Verzenio SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Verzenio Access to Verzenio API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Verzenio patents ...
July 2019
35 pages
Vosevi- Drug Insight, 2019
US$ 1,000.00
... the Vosevi SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Vosevi Access to Vosevi API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Vosevi patents ...
July 2019
35 pages
Xospata- Drug Insight, 2019
US$ 1,000.00
... the Xospata SWOT analysis REASONS TO BUY Establish a comprehensive understanding of the drug, Xospata Access to Xospata API manufacturers details to devise API procurement strategy for generic development Plan developmental timelines around Xospata patents ...
July 2019
35 pages